Kimberly H. Johnson Elected to Lilly Board of Directors
On February 16, 2021, Eli Lilly and Company (NYSE: LLY) appointed Kimberly H. Johnson to its board of directors. Johnson, currently the executive vice president and COO of Fannie Mae, will contribute her expertise in technology, governance, and global risk management. She holds degrees in Economics from Princeton University and an MBA from Columbia Business School. Her addition is expected to enhance the board's capabilities, particularly in financial strategy and oversight.
- Addition of Kimberly H. Johnson is expected to bring a strong background in technology and governance to the board.
- Her experience in risk management may strengthen the company's strategic oversight.
- Concerns about continuity in board composition as new members may need time to acclimatize.
INDIANAPOLIS, Feb. 17, 2021 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has elected Kimberly H. Johnson as a new member, effective February 16, 2021. As a member of Lilly's board, she will serve on both the Compensation Committee and the Ethics and Compliance Committee.
Ms. Johnson currently serves as executive vice president and chief operating officer of the Federal National Mortgage Association ("Fannie Mae") and is a member of Fannie Mae's Management Committee. Prior to serving as executive vice president and chief operating officer, Ms. Johnson held various leadership positions with Fannie Mae, including chief risk officer. Before joining Fannie Mae in 2006, Ms. Johnson was a director at Credit Suisse Group AG.
"I'm very pleased to welcome Kimberly Johnson to the Lilly board of directors," said David A. Ricks, chairman and chief executive officer. "Kimberly brings a strong background in technology, governance and global risk management strategy, as well as significant financial experience. We are excited to add an executive of her caliber and leadership experience to our board."
Ms. Johnson holds a Bachelor of Arts degree in Economics from Princeton University and a Master of Business Administration in Finance from Columbia Business School. She is a member of the Board of Trustees for Princeton University and sits on the board of directors for several non-profit organizations.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com. C-LLY
Refer to: | Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media) |
Kevin Hern; hernkr@lilly.com; (317) 209-6325 (Investors) |
View original content to download multimedia:http://www.prnewswire.com/news-releases/kimberly-h-johnson-elected-to-lilly-board-of-directors-301229416.html
SOURCE Eli Lilly and Company
FAQ
Who is Kimberly H. Johnson, elected to Eli Lilly's board of directors?
What experience does Kimberly H. Johnson bring to Eli Lilly?
What committees will Kimberly H. Johnson serve on at Eli Lilly?
When was Kimberly H. Johnson appointed to the Lilly board?
How might Kimberly H. Johnson's appointment affect Eli Lilly's strategy?
